A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/50 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2387920
Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment of sick sinus syndrome and/or sinoatrial conduction disorders.
Le lévosimendane ou le (-)-[[4(1,4,5,6-tétrahydro-4-méthyl-6-oxo-3-pyridazinyl)phényl]hydrazono]-propanedinitrile, précédemment proposé pour le traitement de l'insuffisance cardiaque globale, se révèle utile pour le traitement de la maladie du sinus et/ou des troubles de la conduction sino-auriculaire.
Hosenpud Jeffrey
Lehtonen Lasse
Ruda Mikhail
Hosenpud Jeffrey
Orion Corporation
Robic
Ruda Mikhail
LandOfFree
A new use of levosimendan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A new use of levosimendan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A new use of levosimendan will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1883270